Myocardial relaxation in human heart failure: Why sarcomere kinetics should be center-stage.


Journal

Archives of biochemistry and biophysics
ISSN: 1096-0384
Titre abrégé: Arch Biochem Biophys
Pays: United States
ID NLM: 0372430

Informations de publication

Date de publication:
01 2019
Historique:
received: 31 08 2018
revised: 12 10 2018
accepted: 13 11 2018
pubmed: 18 11 2018
medline: 28 10 2019
entrez: 18 11 2018
Statut: ppublish

Résumé

Myocardial relaxation is critical for the heart to allow for adequate filling of the ventricles prior to the next contraction. In human heart failure, impairment of myocardial relaxation is a major problem, and impacts most patients suffering from end-stage failure. Furthering our understanding of myocardial relaxation is critical in developing future treatment strategies. This review highlights processes involved in myocardial relaxation, as well as governing processes that modulate myocardial relaxation, with a focus on impairment of myocardium-level relaxation in human end-stage heart failure.

Identifiants

pubmed: 30447209
pii: S0003-9861(18)30684-2
doi: 10.1016/j.abb.2018.11.011
pmc: PMC6311133
mid: NIHMS1514316
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

145-148

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL113084
Pays : United States
Organisme : NHLBI NIH HHS
ID : RC1 HL099538
Pays : United States

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Références

Circ Res. 1987 Jul;61(1):70-6
pubmed: 3608112
Circulation. 1992 May;85(5):1743-50
pubmed: 1572031
Circ Res. 2003 Oct 17;93(8):752-8
pubmed: 14500336
Sci Adv. 2015;1(1):
pubmed: 25839057
Am J Physiol Heart Circ Physiol. 2015 Dec 15;309(12):H2077-86
pubmed: 26453335
N Engl J Med. 2004 May 6;350(19):1953-9
pubmed: 15128895
Am J Physiol Heart Circ Physiol. 2007 May;292(5):H2212-9
pubmed: 17209002
Circ Res. 1991 Mar;68(3):836-46
pubmed: 1742869
Pflugers Arch. 2008 Oct;457(1):37-46
pubmed: 18421471
J Heart Lung Transplant. 1997 Nov;16(11):1157-67
pubmed: 9402516
J Physiol. 1979 Jul;292:68P-69P
pubmed: 490405
J Mol Cell Cardiol. 2004 Jan;36(1):33-42
pubmed: 14734045
Pharmacol Ther. 2014 Mar;141(3):235-49
pubmed: 24140081
J Physiol. 1978 Oct;283:469-80
pubmed: 722587
Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1741-9
pubmed: 20852049
J Gen Physiol. 1995 Jan;105(1):1-19
pubmed: 7730787
Circulation. 1990 Oct;82(4):1266-78
pubmed: 2205417
Cardiovasc Res. 2008 Mar 1;77(4):619-26
pubmed: 18079104
J Physiol. 1982 Jun;327:79-94
pubmed: 7120151
J Mol Cell Cardiol. 2018 Aug;121:81-93
pubmed: 29981798
Circ Res. 1992 Jun;70(6):1225-32
pubmed: 1576741
Circ Heart Fail. 2009 Sep;2(5):472-81
pubmed: 19808378
J Clin Invest. 1991 Mar;87(3):1023-31
pubmed: 1999483
J Gen Physiol. 2013 Jan;141(1):133-9
pubmed: 23277479
Am J Physiol Heart Circ Physiol. 2002 Feb;282(2):H499-507
pubmed: 11788397
J Clin Invest. 1990 May;85(5):1599-613
pubmed: 2332508
Eur Heart J. 1994 Feb;15(2):164-70
pubmed: 8005115
J Mol Cell Cardiol. 1985 Sep;17(9):821-40
pubmed: 3900426
Cardiovasc Res. 1996 Aug;32(2):344-50
pubmed: 8796122
J Pharmacol Exp Ther. 1997 Jan;280(1):247-54
pubmed: 8996203
Circ Heart Fail. 2013 May;6(3):606-19
pubmed: 23616602
Circ Res. 1999 Jul 9;85(1):38-46
pubmed: 10400909
Pflugers Arch. 1997 Nov;434(6):795-800
pubmed: 9306014
Circulation. 1990 Feb;81(2 Suppl):III1-7
pubmed: 2137051
Pflugers Arch. 2008 May;456(2):267-76
pubmed: 18057959
J Am Coll Cardiol. 2004 Aug 18;44(4):837-45
pubmed: 15312868
J Mol Cell Cardiol. 2010 May;48(5):1023-8
pubmed: 20298699
Am J Physiol Heart Circ Physiol. 2010 Oct;299(4):H1092-9
pubmed: 20656885
J Mol Cell Cardiol. 2017 Feb;103:65-73
pubmed: 28087265
Nature. 1982 Jul 8;298(5870):182-4
pubmed: 6211626
J Clin Invest. 1996 Aug 1;98(3):764-76
pubmed: 8698869
Circulation. 2002 Jul 23;106(4):447-53
pubmed: 12135944
Circ Res. 2002 Jun 14;90(11):1150-2
pubmed: 12065316
Biophys Rev. 2014 Dec;6(3-4):273-289
pubmed: 28510030
J Mol Cell Cardiol. 2008 Jul;45(1):32-43
pubmed: 18439620
Am J Physiol Heart Circ Physiol. 2002 Mar;282(3):H1055-62
pubmed: 11834504
J Mol Cell Cardiol. 2010 May;48(5):843-50
pubmed: 20060002
Circ Res. 2016 Jul 22;119(3):418-21
pubmed: 27458197
Am J Physiol Heart Circ Physiol. 2009 Jul;297(1):H247-56
pubmed: 19395549

Auteurs

Paul M L Janssen (PML)

Department of Physiology and Cell Biology, The Ohio State University Wexner Medical Center, USA; Dorothy M. Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center, USA; Department of Internal Medicine, The Ohio State University Wexner Medical Center, USA. Electronic address: janssen.10@osu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH